Quick Takeaways
- Gaurav Shah has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $8,658,782.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Gaurav Shah
- Location
- New York, NY
- Summary
- The estimated net worth of Gaurav Shah is at least $8,658,782 dollars as of 20 Feb 2026. Gaurav Shah is the CEO of ROCKET PHARMACEUTICALS, INC. and owns shares of ROCKET PHARMACEUTICALS, INC. (RCKT) stock worth about $8.66M.
- Signature
- /s/ Martin Wilson, as attorney-in-fact for Gaurav Shah
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Gaurav Shah and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: ROCKET PHARMACEUTICALS, INC. ($8,658,782).
- Past-year value change for that position: -$117,545.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Gaurav Shah
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RCKT, RCKTW | ROCKET PHARMACEUTICALS, INC. | Ceo | $8,658,782 | -$117,545 | -1.3% | 18 Feb 2026 |
| TALS | Talaris Therapeutics, Inc. | Director | 13 Jun 2023 |
Insider Transactions Reported by Gaurav Shah:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.